$11.82
Insights on R1 Rcm Inc
Revenue is up for the last 8 quarters, 385.7M → 575.1M (in $), with an average increase of 5.3% per quarter
Netprofit is up for the last 5 quarters, -37.1M → 1.4M (in $), with an average increase of 3137.7% per quarter
In the last 1 year, Healthequity Inc has given 46.8% return, outperforming this stock by 69.1%
In the last 3 years, Healthequity Inc has given 3.6% return, outperforming this stock by 59.8%
2.71%
Downside
Day's Volatility :2.71%
Upside
0.0%
24.96%
Downside
52 Weeks Volatility :52.57%
Upside
36.79%
Period | R1 Rcm Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 14.2% | 0.5% | 0.0% |
6 Months | 6.01% | 11.7% | 0.0% |
1 Year | -22.29% | 6.2% | 2.2% |
3 Years | -56.19% | 13.5% | -23.0% |
Market Capitalization | 4.9B |
Book Value | $6.55 |
Earnings Per Share (EPS) | 0.01 |
PE Ratio | 1152.8 |
PEG Ratio | 3.22 |
Wall Street Target Price | 16.93 |
Profit Margin | 0.15% |
Operating Margin TTM | 13.34% |
Return On Assets TTM | 3.29% |
Return On Equity TTM | 0.12% |
Revenue TTM | 2.3B |
Revenue Per Share TTM | 5.39 |
Quarterly Revenue Growth YOY | 7.8% |
Gross Profit TTM | 361.3M |
EBITDA | 543.5M |
Diluted Eps TTM | 0.01 |
Quarterly Earnings Growth YOY | -0.99 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.23 |
EPS Estimate Current Quarter | 0.02 |
EPS Estimate Next Quarter | 0.02 |
What analysts predicted
Upside of 43.23%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 868.5M | ↑ 93.09% |
Net Income | -45.3M | ↓ 22.96% |
Net Profit Margin | -5.22% | ↑ 7.85% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 1.2B | ↑ 36.57% |
Net Income | 12.0M | ↓ 126.49% |
Net Profit Margin | 1.01% | ↑ 6.23% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 1.3B | ↑ 7.14% |
Net Income | 115.2M | ↑ 860.0% |
Net Profit Margin | 9.07% | ↑ 8.06% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 1.5B | ↑ 16.04% |
Net Income | 87.3M | ↓ 24.22% |
Net Profit Margin | 5.92% | ↓ 3.15% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 1.8B | ↑ 22.5% |
Net Income | -57.6M | ↓ 165.98% |
Net Profit Margin | -3.19% | ↓ 9.11% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 2.3B | ↑ 24.79% |
Net Income | 3.3M | ↓ 105.73% |
Net Profit Margin | 0.15% | ↑ 3.34% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 496.0M | ↑ 26.56% |
Net Income | -29.5M | ↑ 44.61% |
Net Profit Margin | -5.95% | ↓ 0.74% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 532.8M | ↑ 7.42% |
Net Income | -37.1M | ↑ 25.76% |
Net Profit Margin | -6.96% | ↓ 1.01% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 545.6M | ↑ 2.4% |
Net Income | 300.0K | ↓ 100.81% |
Net Profit Margin | 0.05% | ↑ 7.01% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 560.7M | ↑ 2.77% |
Net Income | 300.0K | ↑ 0.0% |
Net Profit Margin | 0.05% | ↑ 0.0% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 572.8M | ↑ 2.16% |
Net Income | 1.3M | ↑ 333.33% |
Net Profit Margin | 0.23% | ↑ 0.18% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 575.1M | ↑ 0.4% |
Net Income | 1.4M | ↑ 7.69% |
Net Profit Margin | 0.24% | ↑ 0.01% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 807.5M | ↑ 140.33% |
Total Liabilities | 801.2M | ↑ 164.77% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 929.1M | ↑ 15.06% |
Total Liabilities | 911.0M | ↑ 13.7% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.2B | ↑ 27.97% |
Total Liabilities | 849.6M | ↓ 6.74% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.4B | ↑ 21.89% |
Total Liabilities | 1.1B | ↑ 29.78% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 5.1B | ↑ 254.64% |
Total Liabilities | 2.4B | ↑ 119.42% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 5.0B | ↓ 3.49% |
Total Liabilities | 2.2B | ↓ 8.7% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 5.1B | ↓ 0.18% |
Total Liabilities | 2.3B | ↓ 1.12% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 5.1B | ↑ 1.16% |
Total Liabilities | 2.4B | ↑ 4.58% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.1B | ↓ 1.31% |
Total Liabilities | 2.4B | ↓ 2.73% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.1B | ↑ 0.03% |
Total Liabilities | 2.3B | ↓ 0.93% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.1B | ↓ 0.34% |
Total Liabilities | 2.3B | ↓ 1.53% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.0B | ↓ 1.91% |
Total Liabilities | 2.2B | ↓ 3.78% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 18.3M | ↓ 12.44% |
Investing Cash Flow | -496.3M | ↑ 1377.08% |
Financing Cash Flow | 377.4M | ↓ 9085.71% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 113.9M | ↑ 522.4% |
Investing Cash Flow | -61.0M | ↓ 87.71% |
Financing Cash Flow | -25.3M | ↓ 106.7% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 61.8M | ↓ 45.74% |
Investing Cash Flow | -117.0M | ↑ 91.8% |
Financing Cash Flow | 137.9M | ↓ 645.06% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 264.8M | ↑ 328.48% |
Investing Cash Flow | -340.4M | ↑ 190.94% |
Financing Cash Flow | 31.4M | ↓ 77.23% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -9.9M | ↓ 103.74% |
Investing Cash Flow | -949.5M | ↑ 178.94% |
Financing Cash Flow | 943.0M | ↑ 2903.18% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 26.0M | ↓ 126.97% |
Investing Cash Flow | -31.9M | ↓ 96.37% |
Financing Cash Flow | -26.0M | ↓ 102.55% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 29.6M | ↑ 13.85% |
Investing Cash Flow | -27.6M | ↓ 13.48% |
Financing Cash Flow | -22.5M | ↓ 13.46% |
Sell
Neutral
Buy
R1 Rcm Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
R1 Rcm Inc | -9.08% | 6.01% | -22.29% | -56.19% | 11.09% |
Solventum Corp | -10.52% | -10.52% | -10.52% | -10.52% | -10.52% |
Veeva Systems Inc. | -14.44% | 4.71% | 12.48% | -29.78% | 42.98% |
Ge Healthcare Technologies Inc. | -3.5% | 34.49% | 7.28% | 42.09% | 42.09% |
Healthequity Inc | -0.55% | 10.19% | 46.83% | 3.55% | 8.89% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
R1 Rcm Inc | 1152.8 | 1152.8 | 3.22 | 0.0 | 0.0 | 0.03 | NA | 6.55 |
Solventum Corp | NA | NA | NA | 0.0 | 0.12 | 0.08 | NA | NA |
Veeva Systems Inc. | 62.08 | 62.08 | 1.35 | 4.76 | 0.13 | 0.05 | NA | 28.8 |
Ge Healthcare Technologies Inc. | 27.94 | 27.94 | 20.11 | 4.3 | 0.19 | 0.06 | 0.0 | 15.67 |
Healthequity Inc | 123.75 | 123.75 | 2.29 | 2.19 | 0.03 | 0.03 | NA | 23.63 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
R1 Rcm Inc | Buy | $4.9B | 11.09% | 1152.8 | 0.15% |
Solventum Corp | NA | $11.7B | -10.52% | NA | 16.42% |
Veeva Systems Inc. | Buy | $32.4B | 42.98% | 62.08 | 22.24% |
Ge Healthcare Technologies Inc. | Buy | $38.8B | 42.09% | 27.94 | 8.02% |
Healthequity Inc | Buy | $6.8B | 8.89% | 123.75 | 5.57% |
New Mountain Capital, L.L.C.
BlackRock Inc
Vanguard Group Inc
Citadel Advisors Llc
Sachem Head Capital Management LP
Capital Research & Mgmt Co - Division 3
R1 RCM Inc. is an American revenue cycle management company servicing hospitals, health systems and physician groups across the United States.
Organization | R1 Rcm Inc |
Employees | 29400 |
CEO | Mr. Lee Rivas |
Industry | Health Services |